Europska Unija - estonski - EMA (European Medicines Agency)

galderma international - brimonidiintartraat - nahahaigused - muud dermatoloogilised preparaadid - täiskasvanud patsientidel on mirvaso näidustatud rosaatsea näo erüteemi sümptomaatiliseks raviks.

Europska Unija - estonski - EMA (European Medicines Agency)

servier (ireland) industries ltd - agomelatine - depressiivne häire, suur - psychoanaleptics, - täiskasvanute suurte depressiivsete episoodide ravi.

Europska Unija - estonski - EMA (European Medicines Agency)

les laboratoires servier - agomelatine - depressiivne häire, suur - psychoanaleptics, - täiskasvanute suurte depressiivsete episoodide ravi.

Europska Unija - estonski - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - brexpiprazole - skisofreenia - psühhoeptikumid - skisofreenia ravi.

Europska Unija - estonski - EMA (European Medicines Agency)

astrazeneca ab - tixagevimab, cilgavimab - covid-19 virus infection - prevention of covid-19.

Europska Unija - estonski - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - maribavir - tsütomegaloviiruse infektsioonid - viirusevastased ravimid süsteemseks kasutamiseks - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). tuleks arvesse võtta ametlikke juhiseid sobiva kasutamise kohta viirusevastane ained.

Europska Unija - estonski - EMA (European Medicines Agency)

merck sharp & dohme b.v. - insuliinglargiin - diabeet mellitus - diabeetis kasutatavad ravimid - suhkurtõve ravi täiskasvanutel, noorukitel ja lastel vanuses 2 aastat ja üle selle.

Europska Unija - estonski - EMA (European Medicines Agency)

bioprojet pharma - pitolisant - narkolepsia - muud närvisüsteemi ravimid - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.

Europska Unija - estonski - EMA (European Medicines Agency)

baxalta innovations gmbh - nonacog gamma - hemofiilia b - antihemorraagilised ained - veritsuste ravi ja profülaktika hemofiilia b patsientidel (kaasasündinud ix faktori defitsiit).

Europska Unija - estonski - EMA (European Medicines Agency)

astellas pharma europe b.v. - ensalutamiid - eesnäärmevähk - endokriinset ravi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.